Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: A novel approach

Clinical Nuclear Medicine

Volumn 37, Issue 4, 2012, Pages 366-368

  Belakhlef, Sam ^a   Church, Clifford ^a   Jani, Chirag ^a   Lakhanpal, Suresh ^a  

^a PHOEBE PUTNEY MEMORIAL HOSPITAL   (United States)

Author keywords

bladder cancer detection; blood flow; early dynamic FDG and PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER; BLADDER CANCER; BLADDER WALL; BLOOD RHEOLOGY; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; MALE; TRANSITIONAL CELL CARCINOMA; URINARY EXCRETION;

AGED; BIOLOGICAL TRANSPORT; FLUORODEOXYGLUCOSE F18; HUMANS; LINEAR MODELS; MALE; PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84858112212     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182443110     Document Type: Article

References (14)

1. Beyer T, Townsend DW, Blodgett TM, et al. Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med. 2002;46:24-34. (Pubitemid 34808736)
2. Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging. 2000;3: 223-230.
3. Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics. 2003;23:315-340. (Pubitemid 37431265)
4. Belakhlef A, Jani C, Church C, et al. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study. Clin Nucl Med. 2008;33:271-272. (Pubitemid 351450684)
5. Heicappell R, Mueller-Mattheis V, Reinhardt M, et al. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-(18F)-2-deoxy-D-glucose. Eur Urol. 1999;36:582-587. (Pubitemid 29516289)
6. Kosuda S, Kison PV, Greenough R, et al. Preliminary assessment if fluorine- 18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med. 1997;24:615-620. (Pubitemid 27299740)
7. Apolo A, Riches J, Schoder H, et al. Clinical value of 18F-2-deoxyglucose positron emission tomography (FDG PET) in bladder cancer. 2009: ASCO (Abst):5074.
8. Belakhlef S, Krywicki R, Church C, et al. Early dynamic FDG and PET/CT scans to localize cystovaginal fistula. Clin Nucl Med. 2010;14:35:517-519.
9. Dalton A, Etchebehere E, Ramos C, et al. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med. 2007;48: 764-770. (Pubitemid 47604977)
10. Vicente AM, Castrejón AS, Muñoz AP, et al. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies. J Nucl Med Technol. 2010;38:128-137.
11. Lin WY, Wang KB, Tsai SC, et al. Unexpected accumulation of F-18 FDG in the urinary bladder after bladder irrigation and retrograde filling with sterile saline: a possible pitfall in PET examination. Clin Nucl Med. 2009;34:560-563.
12. Kotzerke J, Prang J, Neumaier B, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med. 2000;27:1415-1419.
13. Shreve P, Chiao PC, Humes HD, et al. Carbon-11-acetate PET imaging in renal disease. J Nucl Med. 1995;36:1595-1601.
14. Oyama N, Akino H, Kanamaru H, et al. C-11 acetate PET imaging of prostate cancer. J Urol. 1999;161(suppl):392.